CurrentRheuma
Get Weekly

Topic · page 6 of 11

Inflammatory myopathies

Dermatomyositis, polymyositis, antisynthetase syndrome, immune-mediated necrotizing myopathy, inclusion body myositis, myositis-specific antibodies, myositis-associated interstitial lung disease and cancer-associated myositis

Briefs 201–240 of 430 placed here, newest publication first

Briefs in Inflammatory myopathies

Newest publication first

  1. Arthritis Res Ther

    Development of differential diagnostic models for distinguishing between limb-girdle muscular dystrophy and idiopathic inflammatory myopathy

    Diagnostic or prognostic study

  2. Rheumatology (Oxford)

    The role of nailfold video-capillaroscopy in the assessment of dermatomyositis

    Cohort study

  3. Arthritis Rheumatol

    Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project

    Case-control study

  4. Rheumatology (Oxford)

    Integrating carotid Doppler, greyscale US, and aortic oscillometry to evaluate macroangiopathy in myositides: the MYOCARD cohort

    Cross-sectional study

  5. Rheumatology (Oxford)

    Nailfold videocapillaroscopy findings correlate with lung outcomes in idiopathic inflammatory myopathies–related interstitial lung disease

    Cohort study

  6. RMD Open

    Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease

    Secondary analysis

  7. Rheumatology (Oxford)

    Prognostic factors for patients with cancer-associated dermatomyositis: a retrospective, multicentre cohort study of 73 patients

    Cohort study

  8. Clin Exp Rheumatol

    Determining patient and carer priorities in inclusion body myositis: a patient-led research study

    Cross-sectional study

  9. Clin Exp Rheumatol

    Predictors of thrombotic events in patients with idiopathic inflammatory myopathies

    Cohort study

  10. Rheumatology (Oxford)

    Type I interferon biomarker in idiopathic inflammatory myopathies: associations of Siglec-1 with disease activity and treatment response

    Secondary analysis

  11. Clin Exp Rheumatol

    The Myositis Clinical Trials Consortium: an international collaborative initiative to promote clinical trials in adult and juvenile myositis

    Cross-sectional study

  12. Arthritis Res Ther

    Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositis

    Mechanistic study

  13. Rheumatology (Oxford)

    Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis

    Cross-sectional study

  14. Rheumatology (Oxford)

    Telitacicept add-on therapy in refractory idiopathic inflammatory myopathy: insights from a pilot study

    Research article

  15. Arthritis Res Ther

    Increased serum level of IL-6 predicts poor prognosis in anti-MDA5-positive dermatomyositis with rapidly progressive interstitial lung disease

    Cohort study

  16. Ann Rheum Dis

    Pathological autoantibody internalisation in myositis

    Mechanistic study

  17. Rheumatology (Oxford)

    Diffusion tensor imaging of vastus lateralis in patients with inflammatory myopathies

    Cross-sectional study

  18. Semin Arthritis Rheum

    One-year survival benefit of plasma exchange in idiopathic inflammatory myositis patients with progressive interstitial lung disease-a systemic review and meta-analysis

    Meta-analysis

  19. Rheumatology (Oxford)

    The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset

    Cross-sectional study

  20. Semin Arthritis Rheum

    Efficacy and safety of a step-down regimen of low dosage of glucocorticoids combined with early administration of synthetic or biologic immunosuppressants in anti-synthetase syndrome: A pilot study

    Cohort study

  21. Clin Exp Rheumatol

    The clinical characteristics of pharyngeal and laryngeal lesions in anti-MDA5-positive dermatomyositis patients

    Cohort study

  22. Rheumatology (Oxford)

    Fibroblast activation protein inhibitor positron emission tomography imaging in muscles of patients with idiopathic inflammatory myopathy

    Cohort study

  23. Rheumatology (Oxford)

    Validation of the International Myositis Assessment and Clinical Studies Group guideline on cancer risk stratification

    Cohort study

  24. Arthritis Res Ther

    Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy

    Cohort study

  25. Arthritis Care Res (Hoboken)

    Benefits of Early Versus Late Initiation of Intravenous Immunoglobulin in the Treatment of Patients With Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Immune‐Mediated Necrotizing Myopathy

    Cohort study

  26. Clin Exp Rheumatol

    TRIM63 and Atrogin-1 are key drivers of systemic and muscle inflammation in patients with idiopathic inflammatory myopathies

    Mechanistic study

  27. Ann Rheum Dis

    Protein kinase R is highly expressed in dermatomyositis and promotes interferon-beta-induced muscle damage

    Mechanistic study

  28. Arthritis Rheumatol

    Muscle Tissue Transcriptome of Idiopathic Inflammatory Myopathy Reflects the Muscle Damage Process by Monocytes and Presence of Skin Lesions

    Mechanistic study

  29. Rheumatology (Oxford)

    Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease

    Secondary analysis

  30. Rheumatology (Oxford)

    Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies

    Diagnostic or prognostic study

  31. Rheumatology (Oxford)

    Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-centre prospective observational study of decentralized remote vs. traditional clinic enrolment

    Cohort study

  32. Arthritis Res Ther

    Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy

    Cohort study

  33. Clin Exp Rheumatol

    Different phenotypic manifestations between Brazilian and Japanese anti-MDA5 antibody-positive dermatomyositis: an international tricentric longitudinal study

    Cohort study

  34. Semin Arthritis Rheum

    Clinical characteristics of idiopathic inflammatory myopathies patients with anti-PM/Scl antibodies

    Cohort study

  35. Semin Arthritis Rheum

    Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group

    Cross-sectional study

  36. Semin Arthritis Rheum

    Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies

    Cohort study

  37. Semin Arthritis Rheum

    Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international network

    Cohort study

  38. Rheumatology (Oxford)

    Circulating cell-free DNA promotes inflammation in dermatomyositis patients with anti-NXP2 antibodies via the cGAS/STING pathway

    Mechanistic study

  39. J Rheumatol

    The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms

    Cohort study

  40. Rheumatology (Oxford)

    Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review

    Meta-analysis

All 430 Briefs in ExploreShowing Briefs 201–240 of 430, newest first